REGINA SWENTON: Open Payments
NPI 1972019636 · OKLAHOMA CITY, OK. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$472 in 13 payments from 5 companies in 2025. Trend: 2023 $169 · 2024 $304 · 2025 $472
Food & beverage: $397Education: $75
| Company | Payments | Amount |
|---|---|---|
| Kite Pharma, Inc. | 4 | $225 |
| Astellas Pharma US Inc | 4 | $148 |
| AstraZeneca Pharmaceuticals LP | 3 | $61 |
| Legend Biotech USA Inc. | 1 | $24 |
| Daiichi Sankyo Inc. | 1 | $14 |
Products named: Yescarta, Cresemba, CALQUENCE, CARVYKTI, Vanflyta.
Industry payments across OK — which companies pay providers there.
